期刊文献+

儿童特应性皮炎患者外周血IL-17及IL-8的表达研究 被引量:2

Expression of interleukin-17 and interleukin-8 in peripheral blood children inpatients with atopic dermatitis
下载PDF
导出
摘要 目的检测儿童特应性皮炎患者外周血白介素-17(IL-17)及白介素-8(IL-8)的表达水平,探讨其在儿童AD发病机制中的作用。方法采用双抗体夹心酶联免疫吸附试验(sandwich ELISA)检测60例儿童AD患者外周血IL-17、IL-8的表达情况,并用SCORAD评分标准判断AD患者病情严重程度。30例性别、年龄匹配的健康儿童作为对照组。结果 AD组患者血清IL-17的表达为(35.71±1.78)pg/ml,高于健康对照组(24.22±6.02)pg/ml,差异有统计学意义(t=3.66,P<0.05),且与SCORAD得分呈明显正相关(r=0.646,P<0.05);AD组患者血清IL-8的表达为(69.90±7.78)pg/ml,明显高于健康对照组(34.07±13.04)pg/ml,差异有统计学意义(t=4.72,P<0.01),且与SCORAD得分呈显著正相关(r=0.683,P<0.05)。结论儿童AD患者外周血IL-17、IL-8过度表达可能参与了AD的发病机理。 Objective To detect the expression level of interleukin-17(IL-17)and interleukin-8 (IL-8) in peripheral blood in the patients with atopic dermatitis of children, study the pathogenesis in the AD patients. Methods Peripheral blood was obtained from 60 patients with AD of children and 30 children as a control by sandwich enzyme-linked immunosorbent assay ( sandwich ELISA);with matched gender and age in both groups. And their relationship with AD disease severity were analyzed.AD disease severity scored with SCORAD criterion. Results The serum concentrations of IL-17 in the patients with AD of children (35.71 ±1.78pg/ml) was significantly higher than the healthy controls (24.22 ±6.02pg/ml) ( t =3.66,P 〈0.05) and positively correlated with SCORAD score in AD (r=0.646,P〈0.05).The serum concentrations of IL-8 in the patients with AD(69.90 ±7.78pg/ml)was significantly higher than the healthy controls(34.07 ±13.04pg/ml)(t=4.72, P〈0.01)and positively correlated with SCORAD score in AD (r=0.683,P〈0.05).Conclusions The high expression level of IL-17 and IL-8 in peripheral blood plays the important role in the pathogenesis of AD.
作者 付金玲
出处 《齐齐哈尔医学院学报》 2015年第12期1747-1748,共2页 Journal of Qiqihar Medical University
关键词 特应性皮炎 IL-17 IL-8 Atopic dermatitis Interleukin-17 Interleukin-8
  • 相关文献

参考文献10

二级参考文献47

  • 1Brown S, Reynolds NJ. Atopic and non-atopic eczema. BMJ. 2006, 332(7541 ): 584-588.
  • 2Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy, 2006, 61 (8): 969-987.
  • 3Lipozencic J, Wolf R. Atopic dermatitis: an update and review of the literature. Dermatol Clin, 2007, 25(4): 605-612.
  • 4Williams HC, Burney PG, Hay RJ, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol, 1994, 131(3): 383-396.
  • 5Epstein J, Sanderson IR, MacDonald TT. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies[J]. Br J Nutr, 2010, 103(11) : 1545 -1557.
  • 6Ouyang WJ, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation [J]. hnmunity, 2008, 28 (4) :454 -467.
  • 7Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-AACT method [ J]. Methods, 2001, 25(4):402-408.
  • 8Homey B, DieuvNosjean MC, Wiesenborn A, et al. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis [J]. J Immunol, 2000, 164(12) :6621 -6632.
  • 9Nickoloff BJ. Cracking the cytokine code in psoriasis [ J]. Nature Medicine, 2007, 13(3) :242 -244.
  • 10Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease [ J]. Immunology, 2010, 129(3) :311 -321.

共引文献111

同被引文献16

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部